New METPlatform allows researchers to test drugs for possible use in brain metastases

It is estimated that about a quarter of cancer patients are at risk of brain metastases, a rate that is increasing especially among those who suffer relapses after having undergone different cancer treatments.

Related Keywords

Albacete ,Castilla La Manacha ,Spain ,Spanish ,Complejo Hospitalario Universitario ,Cunqueiro Complejo Hospitalario ,Eva Ortega Pa ,Manuel Valiente ,Emily Henderson ,National Cancer Research Centre ,Spanish Ministry Of Science ,Breast Cancer Clinical Research Unit ,Cancer Research Institute ,Health Institute ,National Brain Metastasis Network ,Melanoma Research Alliance ,Worldwide Cancer Research ,Experimental Therapeutics Programme ,Brain Metastasis Group ,Beug Foundation ,European Research Council ,Spanish Cancer Association ,European Fund For Regional Development ,Hospital Universitario ,Hospital Universitario De La Princesa ,Complejo Hospitalario De Vigo ,Hospital Universitario De Burgos ,Unidad De Investigaci ,Complejo Hospitalario Universitario De Albacete ,Confocal Microscopy ,Molecular Cytogenetics ,Spanish Ministry ,European Fund ,Regional Development ,Metastasis ,Rain ,Brain Metastases ,Dancer ,Drugs ,Hospital ,Laboratory ,Medicine ,Public Health ,Research ,Surgery ,Herapeutics ,